Safety study of VNT-101 in healthy adults
Part of Infections, Lungs & breathing clinical trials.
This first-in-human study tests the safety of a new medicine called VNT-101. Healthy adults aged 18 to 59 who do not smoke and have no major health problems may be able to join. The goal is to see how the body handles the drug and if it is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult between 18 and 59 years old.
- You have not smoked or used nicotine, tobacco, cannabis, or CBD products for at least 3 months (tobacco) or 60 days (cannabis).
- Your body mass index (BMI) is between 18 and 30.
- You have no major medical conditions, including heart disease, high blood pressure, or high cholesterol.
- Women must be unable to become pregnant (surgically sterilized or post-menopausal for at least 1 year). Men must use contraception or be sterilized.
- You have not taken any prescription medications in the last 14 days, and no over-the-counter drugs (except occasional acetaminophen) in the last 7 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called TRX-100 to see if it can help fight the flu. Healthy volunteers will be exposed to the influenza A virus in a controlled setting to see how the medicine works.
This study compares two versions of an antiviral medicine called Ingavirin to see how your body processes them and whether they are safe. Researchers will give you the medicine on an empty stomach and after eating to understand how food affects how your body absorbs it.
This trial tests how safe and tolerable different doses of Ingavirin Forte are in healthy people. It helps find the right dose for future studies.
This trial tests how the body reacts to a specific flu virus (pH1N1) in a controlled setting. Healthy volunteers are exposed to the virus to help researchers understand the infection and test treatments. You will be monitored closely and given antiviral medication if needed.
This early-phase trial tests an experimental oral medication called FB-101 in healthy adult men to check its safety and how the body processes it. It's a first step to see if the drug is safe enough for future studies in patients.
This trial tests a single dose of a new medication (NM-101) in healthy male volunteers to see how the body handles it and if it's safe. It is a phase 1 study that requires you to be in good health and have no major medical conditions.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.